Saphenofemoral arteriovenous fistula as hemodialysis access
<p>Abstract</p> <p>Background</p> <p>An upper limb arteriovenous (AV) fistula is the access of choice for haemodialysis (HD). There have been few reports of saphenofemoral AV fistulas (SFAVF) over the last 10-20 years because of previous suggestions of poor patencies an...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | BMC Surgery |
Online Access: | http://www.biomedcentral.com/1471-2482/10/28 |
_version_ | 1818471380222476288 |
---|---|
author | Vanderlei Luiz Valenti Vitor E Fioretti Alexandre C Yamazaki Yumiko R Breda João R Pires Adilson C de Abreu Luiz Correa João A Junior Hugo Colombari Eduardo Miranda Fausto |
author_facet | Vanderlei Luiz Valenti Vitor E Fioretti Alexandre C Yamazaki Yumiko R Breda João R Pires Adilson C de Abreu Luiz Correa João A Junior Hugo Colombari Eduardo Miranda Fausto |
author_sort | Vanderlei Luiz |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>An upper limb arteriovenous (AV) fistula is the access of choice for haemodialysis (HD). There have been few reports of saphenofemoral AV fistulas (SFAVF) over the last 10-20 years because of previous suggestions of poor patencies and needling difficulties. Here, we describe our clinical experience with SFAVF.</p> <p>Methods</p> <p>SFAVFs were evaluated using the following variables: immediate results, early and late complications, intraoperative and postoperative complications (up to day 30), efficiency of the fistula after the onset of needling and complications associated to its use.</p> <p>Results</p> <p>Fifty-six SFAVF fistulas were created in 48 patients. Eight patients had two fistulas: 8 patent (16%), 10 transplanted (20%), 12 deaths (24%), 1 low flow (2%) and 20 thrombosis (39%) (first two months of preparation). One patient had severe hypotension during surgery, which caused thrombosis of the fistula, which was successfully thrombectomised, four thrombosed fistulae were successfully thrombectomised and revised on the first postoperative day. After 59 months of follow-up, primary patency was 44%.</p> <p>Conclusion</p> <p>SFAVF is an adequate alternative for patients without the possibility for other access in the upper limbs, allowing efficient dialysis with good long-term patency with a low complication rate.</p> |
first_indexed | 2024-04-14T03:50:08Z |
format | Article |
id | doaj.art-cec12140633b4c65bba41e27f5f7b06a |
institution | Directory Open Access Journal |
issn | 1471-2482 |
language | English |
last_indexed | 2024-04-14T03:50:08Z |
publishDate | 2010-10-01 |
publisher | BMC |
record_format | Article |
series | BMC Surgery |
spelling | doaj.art-cec12140633b4c65bba41e27f5f7b06a2022-12-22T02:14:04ZengBMCBMC Surgery1471-24822010-10-011012810.1186/1471-2482-10-28Saphenofemoral arteriovenous fistula as hemodialysis accessVanderlei LuizValenti Vitor EFioretti Alexandre CYamazaki Yumiko RBreda João RPires Adilson Cde Abreu LuizCorrea João AJunior HugoColombari EduardoMiranda Fausto<p>Abstract</p> <p>Background</p> <p>An upper limb arteriovenous (AV) fistula is the access of choice for haemodialysis (HD). There have been few reports of saphenofemoral AV fistulas (SFAVF) over the last 10-20 years because of previous suggestions of poor patencies and needling difficulties. Here, we describe our clinical experience with SFAVF.</p> <p>Methods</p> <p>SFAVFs were evaluated using the following variables: immediate results, early and late complications, intraoperative and postoperative complications (up to day 30), efficiency of the fistula after the onset of needling and complications associated to its use.</p> <p>Results</p> <p>Fifty-six SFAVF fistulas were created in 48 patients. Eight patients had two fistulas: 8 patent (16%), 10 transplanted (20%), 12 deaths (24%), 1 low flow (2%) and 20 thrombosis (39%) (first two months of preparation). One patient had severe hypotension during surgery, which caused thrombosis of the fistula, which was successfully thrombectomised, four thrombosed fistulae were successfully thrombectomised and revised on the first postoperative day. After 59 months of follow-up, primary patency was 44%.</p> <p>Conclusion</p> <p>SFAVF is an adequate alternative for patients without the possibility for other access in the upper limbs, allowing efficient dialysis with good long-term patency with a low complication rate.</p>http://www.biomedcentral.com/1471-2482/10/28 |
spellingShingle | Vanderlei Luiz Valenti Vitor E Fioretti Alexandre C Yamazaki Yumiko R Breda João R Pires Adilson C de Abreu Luiz Correa João A Junior Hugo Colombari Eduardo Miranda Fausto Saphenofemoral arteriovenous fistula as hemodialysis access BMC Surgery |
title | Saphenofemoral arteriovenous fistula as hemodialysis access |
title_full | Saphenofemoral arteriovenous fistula as hemodialysis access |
title_fullStr | Saphenofemoral arteriovenous fistula as hemodialysis access |
title_full_unstemmed | Saphenofemoral arteriovenous fistula as hemodialysis access |
title_short | Saphenofemoral arteriovenous fistula as hemodialysis access |
title_sort | saphenofemoral arteriovenous fistula as hemodialysis access |
url | http://www.biomedcentral.com/1471-2482/10/28 |
work_keys_str_mv | AT vanderleiluiz saphenofemoralarteriovenousfistulaashemodialysisaccess AT valentivitore saphenofemoralarteriovenousfistulaashemodialysisaccess AT fiorettialexandrec saphenofemoralarteriovenousfistulaashemodialysisaccess AT yamazakiyumikor saphenofemoralarteriovenousfistulaashemodialysisaccess AT bredajoaor saphenofemoralarteriovenousfistulaashemodialysisaccess AT piresadilsonc saphenofemoralarteriovenousfistulaashemodialysisaccess AT deabreuluiz saphenofemoralarteriovenousfistulaashemodialysisaccess AT correajoaoa saphenofemoralarteriovenousfistulaashemodialysisaccess AT juniorhugo saphenofemoralarteriovenousfistulaashemodialysisaccess AT colombarieduardo saphenofemoralarteriovenousfistulaashemodialysisaccess AT mirandafausto saphenofemoralarteriovenousfistulaashemodialysisaccess |